RNU6-927P

Across TCGA pan-cancer cohorts, RNU6-927P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU6-927P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-927P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-927P expression acts as an unfavorable survival marker, although some lineages such as UCEC and ESCA show a favorable association.

BLCA, LIHC, and LUAD are the cancer types where RNU6-927P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.307	0.561	.001	75	view →
LIHC	OS	Tertile	II,III,IV	0.084	0.702	<.001	72	view →
LUAD	OS	Tertile	III,IV	0.145	0.690	<.001	63	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	54	view →
CESC	OS	Tertile	All	0.222	0.609	<.001	54	view →
LGG	DFS	Tertile	All	0.269	0.735	<.001	33	view →
READ	DFS	Tertile	III,IV	0.255	0.757	.008	27	view →
KIRC	OS	Tertile	All	0.498	0.643	.033	27	view →
UCEC	OS	Tertile	II,III,IV	1.000	0.465	.033	24	view →
ACC	OS	Tertile	All	0.472	0.841	.002	18	view →
GBM	OS	Tertile	All	0.144	0.421	.004	9	view →
ESCA	DFS	Median	All	0.880	0.391	.034	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RNU6-927P–BLCA (DFS)

Open the BLCA breakdown →